Latest Updates

Articles posted in the "Latest Updates" are compiled and published into a bulletin quarterly.

Previously published articles are available within the Noridian Bulletins webpage. Exclusions to this include time-sensitive announcements such as: Noridian and CMS educational Events, Ask-the-Contractor Teleconferences, and claims processing downtime.

The information included in the Latest Updates is also available by subscribing to the Noridian email list. Medicare news, regulations, workshop notices, and other related notifications will be delivered to you each week. Register Now!

Articles Source Posted
GUIDE Model Implementation CR13412 Jul 18, 2024
Self-Administered Drug Exclusion List (A53032) - R37 - Effective July 1, 2024 Jul 18, 2024
MLN Connects - July 18, 2024 Jul 18, 2024
Polysomnography and Other Sleep Studies - Published for Review and Comments Jul 18, 2024
Medicare Physician Fee Schedule Webinar - 08/22/2024 Jul 17, 2024
Telehealth Enrollment Basics Webinar - 08/14/2024 Jul 17, 2024
Opioid Treatment Program Enrollment Webinar - 08/21/2024 Jul 17, 2024
Documentation Required for Provider Enrollment Webinar - 08/07/2024 Jul 17, 2024
Save the Date: Noridian's Fall 2024 Virtual Symposium - "Cracking Medicare Compliance: A Detective Insight" Jul 17, 2024
Dermatology and Pathology Services Webinar - 08/15/2024 Jul 15, 2024
Evaluation and Management Services Webinar - 08/20/2024 Jul 15, 2024
Medicare Diabetes Prevention Program (MDPP) Webinar - 08/06/2024 Jul 15, 2024
CMS Officially Launched the GUIDE Dementia Model July 1, 2024 Jul 12, 2024
Temporary Disruption to External Print and Mail Services Alert Jul 12, 2024
New Physician Specialty Code for Epileptologists CR13425 Jul 11, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R18 - Effective July 1, 2024 Jul 11, 2024
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R12 - Effective July 1, 2024 Jul 11, 2024
MLN Connects - July 11, 2024 Jul 11, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R7 - Effective July 11, 2024 Jul 11, 2024
Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (A59521) - R2 - Effective July 1, 2024 Jul 11, 2024